Beranda › Migrain › New York › Amherst
Uji klinis Migrain di Amherst, NY
7 studi untuk Migrain mencari peserta di lokasi sekitar Amherst (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of EVO756 in Adults With Migraine
Menerima pesertaFase 2
- Clinosis - Dent Neurologic Instite, Amherst
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Menerima pesertaFase 3
- Dent Neurosciences Research Center, Amherst
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Menerima pesertaFase 3
- Dent Neurosciences Research Center, Amherst
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Menerima pesertaFase 3
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
Responding With Evidence and Access for Childhood Headaches
Menerima peserta
- Dent Neurological Institute, Amherst
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Menerima pesertaFase 3
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Menerima pesertaFase 3
- Dent Neuro Institute, Buffalo, Amherst
- Upstate Clinical Research Associates, Williamsville · 3 mi jauhnya
Uji klinis Migrain di kota lain
- Cincinnati, OH11 studi
- Austin, TX8 studi
- Miami, FL8 studi
- Philadelphia, PA8 studi
- Concord, CA8 studi
- Omaha, NE7 studi
- Houston, TX7 studi
- Washington, DC7 studi
- Aurora, CO6 studi
- Stamford, CT6 studi
- San Diego, CA6 studi
- Tampa, FL6 studi
Studi lain di Amherst
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.